Venture Capital News | Private Equity News
Venture Capital Firms List / Venture Capital & Private Equity Firms and Sources
Published since 1998, VCPro Database is the most reliable, up-to-date and affordable venture capital directory
2023 New Edition Now Available!
(Updated JANUARY 2023)
Learn More Buy Now
VCPro Database 2023 26th Edition — a downloadable and searchable venture capital database with 6,900+ venture capital and private equity firms worldwide. The most reliable, up-to-date and affordable venture capital directory of its kind. VCPro Database is available in both Windows and macOS versions. It has been published since 1998.
Spectrum Science Receives Strategic Investment from Knox Lane to Fuel Continued Growth
WASHINGTON and SAN FRANCISCO, February 7, 2023-- Spectrum Science ("Spectrum" or "the Company"), an independent, integrated marketing, communications and media firm focused on the pharmaceutical, biotech and broader life science industries today announced that the Company has received a strategic investment from Knox Lane, a growth-oriented investment firm that is focused on partnering with businesses in the services and consumer sectors. The partnership will support the continued expansion of Spectrum's strategic communications capabilities, while also enabling the Company to build on its unique approach to clinical trial recruitment, broaden consultative capabilities for medical affairs clients and drive enhanced tech enablement throughout the organization.
Owned by industry veteran Jonathan Wilson, Spectrum has been serving clients across the healthcare sector for nearly three decades. The Company has experienced robust organic growth under Wilson's leadership over the last nine years and completed three successful acquisitions in 2022. Today, Spectrum employs more than 300 individuals across the U.S. and UK.
"Spectrum has been on an incredible trajectory over the past several years, including a particularly prolific 2022," said Shamik Patel, Partner at Knox Lane, and Brent Gunderson, Principal at Knox Lane. "Spectrum's unique model allows them to respond to the evolving needs of pharma, biotech and life science clients in a dynamic and challenging industry and deliver game-changing solutions across commercialization, including strategic communications, advertising, clinical trial recruitment, scientific strategy and medical communications. We're honored to be Spectrum's first institutional partner and look forward to working with Jonathan and the management team on the next stage of the Company's journey and supporting even more growth milestones in the years ahead."
"A number of firms have expressed interest in Spectrum over the years, but we purposefully waited for the right time and opportunity—specifically a partnership that would strategically fuel our expansion while protecting what we feel makes us unique," said Wilson. "We've built a solid team, structure and culture that puts people at the center—from the clients we serve, to the patients they help, to the colleagues we collaborate with around the world. As our organization continues to evolve, our vision remains: to build differentiated capabilities that predict and solve healthcare clients' most pressing challenges. We value the experience and capabilities of Knox Lane and are excited to partner with them on our continued transformation."
Wilson will continue in his role of Chief Executive Officer with the support of Spectrum's established leadership team and will also serve as an Executive Member of the Board.
Houlihan Lokey, Inc. served as the exclusive financial advisor and Alston & Bird LLP acted as legal counsel to Spectrum. Jefferies served as financial advisor and Kirkland & Ellis LLP acted as legal counsel to Knox Lane.
About Spectrum Science
Spectrum Science is an integrated marketing, communications and media firm like no other. An independent, full-service organization with end-to-end capabilities, Spectrum's team are experts in healthcare and science – focused on strategic engagements with our audiences. We leverage human-centered insights, motivating creative, innovative storytelling and technology to reach audiences where they are with the content they need and want. Spectrum offers global reach as the US partner and chair of Global Health Marketing & Communications (GHMC). For more information on how Spectrum goes Beyond the Science Quo, visit www.spectrumscience.com or follow @SpectrumScience on Twitter.
About Knox Lane
Based in San Francisco, Knox Lane is a growth-oriented investment firm comprised of a team of accomplished investors and operators with a shared work history and a strong track record of partnering with leading companies to accelerate transformational growth. Knox Lane employs an investor-operator mindset and seeks to provide support across a number of business components, including human capital, brand management, end-to-end digital transformation, sourcing, supply chain and logistics, strategic acquisitions and business development. For more information, please visit www.knoxlane.com.